MIMMI, SELENA
 Distribuzione geografica
Continente #
NA - Nord America 791
EU - Europa 455
AS - Asia 59
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 1.320
Nazione #
US - Stati Uniti d'America 754
IT - Italia 290
SE - Svezia 54
CA - Canada 36
GB - Regno Unito 30
DE - Germania 26
IN - India 19
FR - Francia 13
CN - Cina 10
RO - Romania 9
KR - Corea 8
BR - Brasile 7
PL - Polonia 7
JP - Giappone 5
FI - Finlandia 4
PT - Portogallo 4
RU - Federazione Russa 4
UA - Ucraina 4
GR - Grecia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
ES - Italia 2
EU - Europa 2
HK - Hong Kong 2
HU - Ungheria 2
ID - Indonesia 2
IR - Iran 2
NZ - Nuova Zelanda 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
DK - Danimarca 1
LK - Sri Lanka 1
MN - Mongolia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 1.320
Città #
Chandler 167
Catanzaro 79
Lawrence 60
Princeton 60
Ottawa 31
Wilmington 30
Seattle 25
Ashburn 24
London 24
Des Moines 20
Chicago 16
Napoli 14
Rome 13
Redmond 9
Augusta 8
Redwood City 8
Foggia 7
Marano 6
Modena 6
Norwalk 6
Paris 6
Seoul 6
Hanover 5
Milan 5
Pune 5
Teresina 5
Chennai 4
Heidesheim 4
Helsinki 4
Latina 4
Munich 4
Naples 4
Providence 4
Reggio Calabria 4
Târgu Mureş 4
Crosia 3
Derby 3
Felgueiras 3
Ferrara 3
Huddinge 3
San Jose 3
Shanghai 3
Villanova d'Asti 3
Washington 3
Adrano 2
Auckland 2
Bagnara Calabra 2
Boardman 2
Bonn 2
Clearwater 2
Cosenza 2
Dubai 2
Edmonton 2
Genoa 2
Jülich 2
Livorno 2
Lowell 2
Ludhiana 2
Milazzo 2
Montalto Uffugo 2
Nanchang 2
Omaha 2
Palembang 2
Romainville 2
Saint-Fons 2
Songpa-gu 2
São Paulo 2
Timisoara 2
Torre Del Lago 2
Vibo Valentia 2
Warsaw 2
Bergamo 1
Bogen 1
Boston 1
Braga 1
Cava Dei Tirreni 1
Cheltenham 1
College Station 1
Colombo 1
Corigliano Calabro 1
Crotone 1
Dallas 1
Eden Prairie 1
Fiumicino 1
Florence 1
Fremont 1
Genova 1
Giarre 1
Guangzhou 1
Guiyang 1
Halifax 1
Istanbul 1
Josho 1
Kuala Lumpur 1
Las Vegas 1
Leawood 1
Los Angeles 1
Madrid 1
Messina 1
Milwaukee 1
Totale 791
Nome #
PEPTIDI E LORO USI 54
Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes 54
A Candidate multi-targeting approach to block the CD98hc oncoprotein 50
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 44
Phage display-derived peptides as tool for single B cell populations targeting in polyclonal CLL patients 37
Evidence for a novel Cullin-3/IBtk human ubiquitin ligase complex 32
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 32
Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia 32
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α 31
Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations 31
The expression of inhibitor of bruton's tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis 30
PEPTIDE AND USES THEREO 29
CRL3IBTK Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation 28
Evolutionary screening and adsorption behavior of engineered M13 bacteriophage and derived dodecapeptide for selective decoration of gold interfaces. 28
Serum Programmed death-ligand 1 (PD-L1) as biomarker or response for anti-PD-L1 immunotherapy 28
Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α 28
Molecular characterization of tumor-derived exosomes as tool for minimal residual disease monitoring 26
CRL3IBTK regulates the tumor suppressor Pdcd4 through ubiquitylation coupled to proteasomal degradation 26
Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors 25
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappaB 25
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 24
A novel phage display based platform for exosome diversity characterization 24
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 23
From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases 23
Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet 22
Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassays 22
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 22
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 21
The expression of Inhibitor of Bruton’s Tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukemia conferring resistance to apoptosis 20
Crucial role for IBtk in the survival and maintenance of mature B cells 20
Insights into Thymus Development and Viral Thymic Infections 20
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival 20
Id-peptides as new tools for diagnosis and treatment of B-cell Chronic Lymphocytic Leukemia (B-CLL) 19
Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients 19
Id-peptides as biomarkers of B-cell Chronic Lymphocytic Leukemia 19
Id peptide-based methodology to explore the antigenic diversity of B-cell Chronic Lymphocytic Leukemia (B-CLL) 19
Phage-displayed peptides for targeting tyrosine kinase membrane receptors in cancer therapy 19
Phage Display: An Overview in Context to Drug Discovery 18
Phage Display: An Overview in Context to Drug Discovery 17
Abstract 1814: Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 17
IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E- myc Mice 17
Insights about myc and apoptosis in b-lymphomagenesis: An update from murine models 17
Exosome-associated miRNAs profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 17
IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells 16
Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay 15
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 15
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 15
IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis 15
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 15
Harnessing the potential of idiotypic peptide therapy for the treatment of multiple myeloma 14
Molecular modeling of epitopes recognized by neoplastic B-cells in Chronic Lymphocytic Leukemia 14
IBtkα Activates the β‐Catenin‐Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3βin Cancerous B Cells 14
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 13
Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring 13
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 11
null 10
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 10
IN VIVO TUMOR TARGETING BY IDIOTYPE-SPECIFIC PEPTIDES 9
Peptide-guided targeting of GPR55 for anti-cancer therapy 9
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 9
Belantamab mafodotin in multiple myeloma 8
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 8
Peptide-guided targeting of GPR55 for anti-cancer therapy. 8
Isatuximab in multiple myeloma 7
Mass Spectrometry-Based Identification of a Tumor Sialoglycoprotein Antigen involved in Cancer Progression 6
null 6
PTPRJ negatively modulates CD98hc-CD147 complex activity in A549 lung cancer cells 5
Idiotype-specific peptides as tools for the specific delivery of therapeutic compounds into tumors 5
The Inhibitor Of Bruton’ Tyrosine Kinase-G Regulates The Btk Signaling In B Cells 5
Peptide binders of BCR as a novel tool to target mature and clonogenic tumor cells in Multiple Myeloma 4
Peptide-Guided Targeting Of Gpr55 For New Therapeutic Strategies Of Cance 4
null 2
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells 1
Totale 1.415
Categoria #
all - tutte 15.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020147 0 0 0 15 48 2 2 17 9 9 9 36
2020/2021176 11 7 6 5 5 26 16 2 33 37 18 10
2021/2022268 6 2 13 56 20 12 15 60 19 34 29 2
2022/2023559 122 26 38 23 52 37 7 53 108 38 41 14
2023/2024265 59 38 31 23 21 65 6 10 6 6 0 0
Totale 1.415